Cancer trials to watch
Ongoing research continues to advance our understanding of the pathogenesis of cancer and has led to the development of early detection techniques and novel therapeutics.
Following rigorous pre-clinical research, only a very select few molecules and therapeutics enter clinical trials for determination of safety and efficacy. Currently, there are promising trials underway for immunotherapies and treatments for rare cancers. There are also trials investigating personalized medicine to address drug resistance, efficacy, and adverse events. As technologies continue to advance, various trials examine the use of digital tools and artificial intelligence in the clinical setting. Coupled with advanced screening and diagnostic techniques for early detection, patients may be able to initiate treatment sooner for better outcomes.
Download the full eBook compliments of Clinical Lab Manager.